Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates. - Wikidata - awgldk - TriplyDB

Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates.

Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates.

http://www.wikidata.org/entity/Q33694562

about

15-lipoxygenase metabolites of docosahexaenoic acid inhibit prostate cancer cell proliferation and survival Specificity of lipoprotein-associated phospholipase A(2) toward oxidized phosphatidylserines: liquid chromatography-electrospray ionization mass spectrometry characterization of products and computer modeling of interactions Regulation of inflammation in cancer by eicosanoids Omega-3 Fatty Acids and Cancer Cell Cytotoxicity: Implications for Multi-Targeted Cancer Therapy Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs 15-Lipoxygenase-1-mediated metabolism of docosahexaenoic acid is required for syndecan-1 signaling and apoptosis in prostate cancer cells Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasound Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation.Synthesis of the novel (±)-2-methoxy-6-icosynoic acid--a fatty acid that induces death of neuroblastoma cells.ω-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-α Effect of polyunsaturated fatty acids on drug-sensitive and resistant tumor cells in vitro Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53 Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain.The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential Inhibition of the HER2 pathway by n-3 polyunsaturated fatty acids prevents breast cancer in fat-1 transgenic mice.Interactions between α-tocopherol, polyunsaturated fatty acids, and lipoxygenases during embryogenesis.Novel liquid chromatography-mass spectrometry method shows that vitamin E deficiency depletes arachidonic and docosahexaenoic acids in zebrafish (Danio rerio) embryos Lipidomics of oxidized polyunsaturated fatty acids Profiling the regulatory lipids: another systemic way to unveil the biological mystery.Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis.Lipidomics applications in health, disease and nutrition research.The multifaceted effects of omega-3 polyunsaturated Fatty acids on the hallmarks of cancer.Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma.Breaking the cycle: the role of omega-3 polyunsaturated fatty acids in inflammation-driven cancers.Protective role of humanin on bortezomib-induced bone growth impairment in anticancer treatment.Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo.How plausible is the use of dietary n-3 PUFA in the adjuvant therapy of cancer?Effect of Oral Docosahexaenoic Acid (DHA) Supplementation on DHA Levels and Omega-3 Index in Red Blood Cell Membranes of Breast Cancer Patients.Curcuminoids and ω-3 fatty acids with anti-oxidants potentiate cytotoxicity of natural killer cells against pancreatic ductal adenocarcinoma cells and inhibit interferon γ production.Identification of cytotoxic mediators and their putative role in the signaling pathways during docosahexaenoic acid (DHA)-induced apoptosis of cancer cells.Essential fatty acids enhance free radical generation and lipid peroxidation to induce apoptosis of tumor cells Lipoxins, resolvins, protectins, maresins and nitrolipids, and their clinical implications with specific reference to cancer: part I

P2860

Q21134042-01032364-F87D-4A0D-82AB-664A5541AB3A Q23923367-AC38F9E4-E857-401A-82B4-037035C38AA9 Q24564308-99993809-B05A-4FA8-9701-BC8A79E2436A Q26773056-A7DA3A3F-1500-41A5-8386-42487F660B0E Q27014988-56DABAE2-8605-4A85-BBB4-78A835FE90B9 Q28277101-CD24F023-35E9-439A-BA5F-12AABC6A6196 Q30362081-6E09444F-96E9-4071-A0E9-63B201C7F69D Q33784486-9D59D5B8-0885-434D-90B7-4B507CE712A6 Q33948780-C0AF1AA1-6C62-4F22-A871-8EB6C7B637FA Q34428959-89C9EB16-387D-497F-B741-6689303B18BF Q35020458-41766E23-C693-4282-BF14-84FAC804E265 Q35233123-10F286CA-8F6A-44EC-BC17-DA1BC7983D0D Q35623890-C993F211-F009-4586-BB43-5B0E60AAED18 Q35812881-0F5A4CAE-4322-42A9-900B-19B11064DE05 Q37000498-ECFF4FA7-B392-4162-BB21-2F01A2968054 Q37305409-9BC6045F-A105-4867-B41D-4327DA952BA8 Q37416809-CDAB5483-86F5-477B-BD89-1B59B83D92F9 Q37459527-9A239ADC-CA5D-486A-96D7-1F88A846F0DE Q37710484-931B255F-2A38-4F50-9CD9-20A5352E15BE Q37871285-CFAB9D98-F5E0-4DB5-A099-3B8CF1FD186B Q37946729-144E0729-AF92-46F3-AC9B-3FCA4045D1E9 Q38111301-B02ED1B6-BB06-484F-8AC9-D192EE3C8665 Q38114076-2FFF0A23-6F42-4E89-B649-8185233850E1 Q38131891-026FB6AE-D2AE-402F-B222-03975FBD0310 Q38237483-67226120-B7C9-4321-946A-AD5C231F216C Q39019344-15EFBCA5-1046-459A-A657-CE0217D238D2 Q39700720-A2B80153-0948-4193-84D4-4F9F4FC4A09D Q39771420-AB52C80F-AF60-4BAB-8438-3961EEDFAB9B Q40095243-FE642505-6A7A-4917-A110-66BFBF834B80 Q40955488-AEE957A7-28AF-463A-99A4-9B474B708EDC Q51430473-ED9E43D3-13E0-42D2-9F0D-342605A2256B Q56699406-320541C2-C16A-4745-8256-9F0770331C61 Q56699407-2C3CAA86-030E-422D-849A-C5145E5885A3

P2860

Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates.

http://www.wikidata.org/entity/Q33694562

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Docosahexaenoic acid metabolom ...... on of cytotoxic intermediates.

@ast

Docosahexaenoic acid metabolom ...... on of cytotoxic intermediates.

@en

type

label

Docosahexaenoic acid metabolom ...... on of cytotoxic intermediates.

@ast

Docosahexaenoic acid metabolom ...... on of cytotoxic intermediates.

@en

prefLabel

Docosahexaenoic acid metabolom ...... on of cytotoxic intermediates.

@ast

Docosahexaenoic acid metabolom ...... on of cytotoxic intermediates.

@en

P1433

Q33694562-EF98D36E-0256-4390-81A3-16767E59B01A

P1476

Q33694562-165F2992-A6D7-4EF0-842E-1B716F95171E

P2093

Q33694562-41C54496-CB5D-431A-9A66-89C9784B8F5E

Q33694562-B04565E1-C307-41CC-A0D9-71354DA385C2

Q33694562-B72C5E23-C829-4D87-920A-CFAAB44E4E2A

Q33694562-D254F684-7195-4A95-A9B7-E9AF42431BB4

Q33694562-DF040BDD-66D6-4E2E-9B6E-16415859BDDF

P2860

Q33694562-0FA1B453-8D04-4873-9D2B-5093B09F5296

Q33694562-10E5C137-A5BC-4657-A400-0D1579218ECF

Q33694562-13674C33-F513-4D31-AD10-D80240ED10ED

Q33694562-1A430A17-602A-4051-8253-9352122DC704

Q33694562-1D819E30-CBA6-4E31-AC04-C5D80B2251F1

Q33694562-20F24C4C-B608-43E9-94DD-3F509D48F9BA

Q33694562-3292DBCB-1226-4F55-82A4-8100716F6859

Q33694562-385B2601-DBE0-4405-B98C-B9475A83AF71

Q33694562-3E06A41C-67C3-45CD-9E4F-B4143275476D

Q33694562-42EE6F38-FD98-4760-910A-244C5AA7D226

P304

Q33694562-683DFC1F-A667-45A5-8EF3-3A353B032550

P31

Q33694562-FC8A0DE3-03C3-45E7-923B-4D2E43F3F146

P356

Q33694562-8017025E-B88C-4C7A-A36E-A518827B6934

P407

Q33694562-E4D88C4C-7219-4EAC-84B0-86157F5C7024

P433

Q33694562-76311957-952D-42F4-9FA8-D6B0B8F6506F

P478

Q33694562-850B8A17-D127-4F3E-BF36-EAAD1C127BEC

P50

Q33694562-3296504E-4594-45AC-8003-3CA644CF9453

Q33694562-E14F2C6E-0AFF-4EAF-A8B0-E312582C26D7

P577

Q33694562-974D321E-A8DE-4FCB-BDCF-4C8309EC6569

P698

Q33694562-F9E52923-ED1C-4E7E-8880-D7BD334A8468

P921

Q33694562-EDCCDC00-0F49-4AB0-8919-AE0D96FEDC59

P932

Q33694562-2F7F8D5C-8F33-4ED0-8164-59C8B8269B84

P356

P1433

P1476

Docosahexaenoic acid metabolom ...... ion of cytotoxic intermediates

@en

P2093

Charles N Serhan

http://www.w3.org/2001/XMLSchema#string

Helena Gleissman

http://www.w3.org/2001/XMLSchema#string

John Inge Johnsen

http://www.w3.org/2001/XMLSchema#string

Magnus Lindskog

http://www.w3.org/2001/XMLSchema#string

Rong Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

Brain foods: the effects of nutrients on brain function

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

Cancer-related inflammation

Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression

Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers

Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation

Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators

Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo.

The role of one-electron reduction of lipid hydroperoxides in causing DNA damage

P304

906-915

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1096/FJ.09-137919

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Kimberly Martinod

P577

2009-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19890019

http://www.w3.org/2001/XMLSchema#string

P921

P932

2830131

http://www.w3.org/2001/XMLSchema#string